Secondary Open Angle Glaucoma

Patients who underwent Xen gel stent implantation combined with phacoemulsification to treat primary or secondary open-angle glaucoma experienced a similar central endothelial cell density loss at 2 years as those who underwent stand-alone phacoemulsification, according to a study.

Patients treated with iodine-125 brachytherapy for uveal melanoma could have a substantial risk for developing open-angle or neovascular glaucoma.